Is complexity something bad? We don’t think so. For us, complexity is just a fact of life. There is no point in simplifying something when you’re really just throwing away valuable information. The best thing we can do about complexity is to make it manageable. That is what we do with our database software.
For over 20 years now, Stegmann Systems has been developing database software solutions (PLA & APS) for the regulated industry. Their software PLA supports the development, execution and analysis of biological assays and is used by over 700 pharmaceutical and biotech companies worldwide. Among them are the top 100 biotech companies together with laboratories, universities, research institutions and regulatory authorities.
The current version of the PLA 3.0 software supports the analysis of all types of biological assays and provides a range of biostatistical methods for immunoassays, ELISA, and more. Our PLA 3.0 all-in-one software bundle provides many extensions and a fully compliant platform. The platform meets international GMP standards and follows the guidance from the US Pharmacopeia (USP) <111>, <1032>, <1033>, <1034> and European Pharmacopoeia, Chapter 5.3. This leads to PLA currently being the only real and complete compliance software on the market.
The software APS supports organizations in crosslinking, publishing and organizing numerous data collections and is used by leading archives, museums and scientific institutions.
www.stegmannsystems.com
www.aps-info.de
www.bioassay.de
#ssy
#pla30
#aps210
Imprint: https://www.bioassay.de/imprint/
Industry
Software Development, Medical and Diagnostic Laboratories, Health Care and Social Assistance, It Firma, Computer & Software, Computer & Elektronik
HQ Location
Raiffeisenstraße 2
Rodgau (near Frankfurt), 63110, DE
Keywords
Software for Biostatistical AnalysisCompliance with FDA 21 CFR Part 11Good Manufacturing PracticeGMPInstallation QualificationIQOperational QualificationOQPerformance QualificationPQ